Approval · Notice of Compliance 16207 · 2014
DYMISTA: Notice of Compliance 16207
Issued October 23, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16207
- Date
- October 23, 2014
- Company
- Meda Pharmaceuticals Ltd
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antihistamine and corticosteroid agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DYMISTA | 02432889 | Marketed |
Medicinal ingredients
- FLUTICASONE PROPIONATE 50 MCG per ACT
- AZELASTINE HYDROCHLORIDE 137 MCG per ACT